Select Medical Holdings Corp

SEM remains in a Stage 2 advance with a clear higher highs/higher lows structure, yet short-term momentum has flattened and price is stalled at horizontal resistance. We defer engagement and look to re-enter on pullbacks into the rising 9/20/50 EMA and 50 DMA support zone.

• ↑Q1 revenue increased 5% YoY to $1.6B across all divisions
• ↑Inpatient rehab revenue surged 14% YoY to $351.9M with 12% census gain
• ↓Adjusted EBITDA declined 6.5% YoY to $141.6M, impacted by $13–14M acquisition costs